Jin Medical International Limited Announces Financial Results for Six Months Ended March 31, 2023
| ZJYL Stock | 0.75 0.05 6.25% |
About 62% of JIN MEDICAL's investor base is looking to short. The analysis of overall sentiment of trading JIN MEDICAL INTERNATIONAL stock suggests that many investors are alarmed at this time. JIN MEDICAL's investing sentiment shows overall attitude of investors towards JIN MEDICAL INTERNATIONAL.
JIN |
Jin Medical International Limited , a Cayman Islands holding company with Chinese operating entities that manufacture and develop wheelchairs and living aids products, today announced its financial results for the six months ended March 31, 2023 .
Read at finance.yahoo.com
 |
JIN MEDICAL Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards JIN MEDICAL can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
JIN MEDICAL Fundamental Analysis
We analyze JIN MEDICAL's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of JIN MEDICAL using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of JIN MEDICAL based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Shares Owned By Institutions
Shares Owned By Institutions Comparative Analysis
JIN MEDICAL is currently under evaluation in shares owned by institutions category among its peers. Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
JIN MEDICAL INTERNATIONAL Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with JIN MEDICAL stock to make a market-neutral strategy. Peer analysis of JIN MEDICAL could also be used in its relative valuation, which is a method of valuing JIN MEDICAL by comparing valuation metrics with similar companies.
Peers
JIN MEDICAL Related Equities
| ANGO | AngioDynamics | 3.01 | ||||
| MMSI | Merit Medical | 1.67 | ||||
| HOLX | Hologic | 1.37 | ||||
| HAE | Haemonetics | 1.13 | ||||
| RMD | ResMed | 0.19 | ||||
| COO | Cooper Companies, | 0.18 | ||||
| BDX | Becton Dickinson | 0.70 | ||||
| ICUI | ICU Medical | 0.74 | ||||
| ALC | Alcon AG | 0.76 | ||||
| WST | West Pharmaceutical | 0.90 |
Check out JIN MEDICAL Hype Analysis, JIN MEDICAL Correlation and JIN MEDICAL Performance. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 0.02 | Revenue Per Share 0.129 | Quarterly Revenue Growth 0.03 | Return On Assets 0.0403 |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.